Nothing Special   »   [go: up one dir, main page]

CN108567854A - Join Ling oral liquid and preparation method thereof - Google Patents

Join Ling oral liquid and preparation method thereof Download PDF

Info

Publication number
CN108567854A
CN108567854A CN201710941478.8A CN201710941478A CN108567854A CN 108567854 A CN108567854 A CN 108567854A CN 201710941478 A CN201710941478 A CN 201710941478A CN 108567854 A CN108567854 A CN 108567854A
Authority
CN
China
Prior art keywords
parts
oral liquid
ginseng
liquid
ling oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710941478.8A
Other languages
Chinese (zh)
Inventor
秦楠
张朔生
王小敏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanxi University of Chinese Mediciine
Shanxi University of Traditional Chinese Mediciine
Original Assignee
Shanxi University of Traditional Chinese Mediciine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanxi University of Traditional Chinese Mediciine filed Critical Shanxi University of Traditional Chinese Mediciine
Priority to CN201710941478.8A priority Critical patent/CN108567854A/en
Publication of CN108567854A publication Critical patent/CN108567854A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815Lycium (desert-thorn)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/074Ganoderma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Seed ginseng Ling oral liquid of the invention and preparation method thereof, belongs to technical field of traditional Chinese medicines;It is prepared by the raw material of following weight:22 27 parts of Radix Notoginseng, 18 23 parts of American Ginseng, 26 32 parts of ganoderma lucidum, 35 45 parts of matrimony vine, 24 parts of sika deer velvet antler, 7 12 parts of Radix Astragali, 7 12 parts of Radix Glycyrrhizae;The present invention joins Ling oral liquid, and preparation method is simple, fully takes into account the abundant extraction of various drug ingedients in composition, immunity of organisms can effectively be enhanced, and present composition compatibility is reasonable, each raw material used has played synergistic effect, and drug activity is substantially better than each single raw material.

Description

Join Ling oral liquid and preparation method thereof
Technical field
Seed ginseng Ling oral liquid of the invention and preparation method thereof, belongs to technical field of traditional Chinese medicines.
Background technology
Immunity is the defense mechanism of human body itself, is that human bioequivalence and any foreign matter of the external intrusion of elimination are (viral, thin Bacterium etc.);It handles aging, damage, death, the own cells of denaturation and identification and processing vivo mutations cell and virus infection is thin The ability of born of the same parents.The body of hypoimmunity easily incurs the infection such as bacterium, virus, fungi, therefore hypoimmunity is most direct Performance is exactly liable to illness.
The human body of health has natural resistance to bacterium and virus, only the feelings of functional disturbance occurs in human organ Under condition, bacterium or virus could invade and cause to fall ill.Therefore improving immunity of human body itself could be constantly to antiviral Invasion.And effectively Chinese medicine composition has the effect of allomeric function state of adjustment body, raising immunity of organisms.
Invention content
Overcome the deficiencies in the prior art of the present invention, it is a kind of with raising human immunity the technical problem to be solved is that providing Ginseng Ling oral liquid of power and preparation method thereof.
In order to solve the above technical problems, the technical solution adopted in the present invention is:One seed ginseng Ling oral liquid, by following weight The raw material of part proportioning is prepared:22-27 parts of Radix Notoginseng, 18-23 parts of American Ginseng, 26-32 parts of ganoderma lucidum, 35-45 parts of matrimony vine, sika deer It is 2-4 parts fine and soft, 7-12 parts of Radix Astragali, 7-12 parts of Radix Glycyrrhizae.
Preferably, it is prepared by the raw material of following weight:25 parts of Radix Notoginseng, 20 parts of American Ginseng, 30 parts of ganoderma lucidum, 40 parts of matrimony vine, 3 parts of sika deer velvet antler, 10 parts of Radix Astragali, 10 parts of Radix Glycyrrhizae.
The pharmacological property of each raw material is as follows in the present invention:
Radix Notoginseng:Also known as it is invaluable, enrich blood first, the ginseng with tonifying Qi first, taste is most precious person in Chinese medicine also with work(. For Araliaceae herbaceos perennial, sweet in flavor, slight bitter is warm-natured, and principle active component is notoginsenoside, has hemostasis stasis, disappears The effect of swollen analgesic therapy.
American Ginseng:Belong to Araliaceae Panax, belong to one kind of ginseng, is the drug of first choice of qi-tonifying health-care, sweet in flavor, slight bitter, It is cold in nature, containing there are many ginsenoside, volatile oil, carbohydrate, amino acid and inorganic elements etc., can anti anoxia, it is antifatigue, enhance machine The adaptability and immune function of body, can anti-arrhythmia, adjust blood pressure, effectively enhance nervous centralis, can beneficial lung yin, clearly The fire of deficiency type promotes the production of body fluid to quench thirst.
Ganoderma lucidum:Chemical composition mainly has a triterpene compound, polysaccharide, ucleosides, alkaloids, amino acid polypeptide class, Inorganic elements, aliphatic acid etc..Polysaccharide is one of bioactive substance of ganoderma lucidum, has antitumor, immunological regulation, hypoglycemic, drop Blood fat, anti-oxidant and anti-aging effect.
Radix Astragali:Property sweet tepor, be tonifying Qi good medicine, stress qi-restoratives, main component is glycoside, flavonoids, polysaccharide, amino acid Deng with solid table, liver protection diuresis, decompression antibacterial, anti-aging, resisting stress, enhancing body's immunity.
Radix Glycyrrhizae:Belong to pulse family, gas is micro-, sweet and special, and main component has glycyrrhizic acid, liquiritin etc., glycyrrhizin and Huang Letones are most important physiological activators in Radix Glycyrrhizae, have the effect of clearing heat and detoxicating, expelling phlegm and arresting coughing.
Matrimony vine:Main component is glycine betaine, and atropine, hyoscyamine, wolfberry pigment etc., wherein polysaccharides are in matrimony vine Most important active constituent is a kind of water-soluble polysaccharide, and there is antifatigue, antitumor, anti-aging, radioresistance, liver protection to promote to exempt from The effect of epidemic disease.
Sika deer velvet antler:To mend marrow, kidney yang is helped, strengthening the bones and muscles effect and famous, the salty temperature of property sugariness have abundant amino Acid, vitamin and trace element, health-care effect are very high.
A method of ginseng Ling oral liquid is prepared, is included the following steps:
(1) ultrasonic lixiviating effective components-total saposins after taking the Radix Notoginseng of weight, American Ginseng to crush;It will crush first The weight ratio of Radix Notoginseng afterwards, American Ginseng petroleum ether and extracting n-butyl alcohol, liquid material used is 33:1, petroleum ether and n-butanol used Concentration be 49.5%, the volume ratio of petroleum ether and n-butanol used is 1:1;Then again with a concentration of 70% EtOH Sonicate Extraction, ultrasonic time are 28min/ times, and ultrasonic extraction 2 times, ultrasonic temperature is 50 DEG C, obtains saponin(e dry cream;
(2) ganoderma lucidum of weight, sika deer velvet antler, matrimony vine, Radix Astragali, licorice medicinal materials, through crushing using a concentration of are taken The weight ratio of 99.5% petroleum ether, liquid material used is 25:1, it impregnates grease removal for 24 hours, is then extracted with sevage reagents to remove Albumen, is eventually adding a concentration of 75% ethyl alcohol, alcohol precipitation ultrasound lixiviating effective components-total starches, and the weight ratio of liquid material used is 25:1, the volume ratio of ethyl alcohol used and sevage reagents is 1:1, ultrasonic temperature is 75 DEG C, and ultrasonic time is 30min/ times, is surpassed Sound extracts 2 times, obtains polysaccharide extraction liquid;
(3) the saponin(e dry cream obtained by step (1) is mixed with the polysaccharide extraction liquid obtained by step (2), is concentrated into liquid-solid ratio It is 1.2:When 1, clarified solution is obtained with sedimentation separation method;
(4) into clarified solution obtained by step (3), addition flavouring agent joins Ling oral liquid to obtain the final product;The flavouring agent is by following weight The raw material composition of part proportioning:1 part of citric acid, 25 parts of honey, 35 parts of xylitol;
The prepared Ling oral liquid relative density of joining of step (4) is 1.17, PH 4.5, general flavone 1.13%, and total reducing sugar is 14.23%, the clarification of product sepia, uniform color is consistent, palatable free from extraneous odour.
Sevage reagents described in step (2) are chloroform and a concentration of 99% n-butanol is 5 by volume:1 mixing institute .
Compared with prior art the invention has the advantages that.
The present invention joins Ling oral liquid, and preparation method is simple, fully takes into account fully carrying for various drug ingedients in composition It takes, can effectively enhance immunity of organisms, and present composition compatibility is reasonable, each raw material used has played synergistic effect, medicine Effect activity is substantially better than each single raw material.
Specific implementation mode
Below in conjunction with specific embodiment, the invention will be further described.
Embodiment 1
One seed ginseng Ling oral liquid, is prepared by the raw material of following weight:22 parts of Radix Notoginseng, 23 parts of American Ginseng, spirit 26 parts of sesame, 45 parts of matrimony vine, 2 parts of sika deer velvet antler, 12 parts of Radix Astragali, 7 parts of Radix Glycyrrhizae.
A method of ginseng Ling oral liquid is prepared, is included the following steps:
(1) ultrasonic lixiviating effective components-total saposins after taking the Radix Notoginseng of weight, American Ginseng to crush;It will crush first Radix Notoginseng afterwards, American Ginseng petroleum ether and extracting n-butyl alcohol, the solid weight ratio of liquid used are 33:1, petroleum ether and n-butanol used Concentration be 49.5%, the volume ratio of petroleum ether and n-butanol used is 1:1;Then again with a concentration of 70% EtOH Sonicate Extraction, ultrasonic time are 28min/ times, and ultrasonic extraction 2 times, ultrasonic temperature is 50 DEG C, obtains saponin(e dry cream;
(2) ganoderma lucidum of weight, sika deer velvet antler, matrimony vine, Radix Astragali, licorice medicinal materials, through crushing using a concentration of are taken 99.5% petroleum ether, the solid weight ratio of liquid used are 25:1, it impregnates grease removal for 24 hours, is then extracted with sevage reagents to remove Albumen, is eventually adding a concentration of 75% ethyl alcohol, alcohol precipitation ultrasound lixiviating effective components-total starches, and the solid weight ratio of liquid used is 25:1, the volume ratio of ethyl alcohol used and sevage reagents is 1:1, ultrasonic temperature is 75 DEG C, and ultrasonic time is 30min/ times, is surpassed Sound extracts 2 times, obtains polysaccharide extraction liquid;The sevage reagents are chloroform and a concentration of 99% n-butanol is 5 by volume: 1 mixing gained;
(3) the saponin(e dry cream obtained by step (1) is mixed with the polysaccharide extraction liquid obtained by step (2), is concentrated into liquid-solid ratio It is 1.2:When 1, clarified solution is obtained with sedimentation separation method;
(4) into clarified solution obtained by step (3), addition flavouring agent joins Ling oral liquid to obtain the final product;The flavouring agent is by following weight The raw material composition of part proportioning:1 part of citric acid, 25 parts of honey, 35 parts of xylitol;
Prepared ginseng Ling oral liquid relative density be 1.17, PH 4.5, general flavone 1.13%, total reducing sugar 14.23%, Product sepia is clarified, and uniform color is consistent, palatable free from extraneous odour.
Embodiment 2
One seed ginseng Ling oral liquid, is prepared by the raw material of following weight:27 parts of Radix Notoginseng, 18 parts of American Ginseng, spirit 32 parts of sesame, 35 parts of matrimony vine, 4 parts of sika deer velvet antler, 7 parts of Radix Astragali, 12 parts of Radix Glycyrrhizae.
A method of ginseng Ling oral liquid being prepared, with embodiment 1.
Embodiment 3
One seed ginseng Ling oral liquid, is prepared by the raw material of following weight:25 parts of Radix Notoginseng, 20 parts of American Ginseng, spirit 30 parts of sesame, 40 parts of matrimony vine, 3 parts of sika deer velvet antler, 10 parts of Radix Astragali, 10 parts of Radix Glycyrrhizae.
A method of ginseng Ling oral liquid being prepared, with embodiment 1.
Test example
The effect of to examine the present invention to improve immunity, test mouse.
Test example 1, influence experiment of the present composition to mouse immune organ thymus gland, spleen weight.
Mouse (14~18g) 40 is taken, is randomly divided into 4 groups, blank control group and treatment group.Treatment group is given respectively to implement Ginseng Ling oral liquid prepared by example 1,2,3;Blank control group gives isometric physiological saline.It is 0.2ml/ to give volume 10g, 1 times/day of gavage, continuous gavage 10 days, the next day after last gavage put to death mouse, weigh, take spleen, thymus gland, liver Claim weight in wet base, using the ratio between weight (mg) and weight (g) of thymus gland or spleen as thymus gland or spleen index.
Test result:
Join influence of the Ling oral liquid to mouse thymus index and spleen index
Note:The * P < 0.05 compared with blank group, * * P < 0.01.
As seen from the above table, the ginseng Ling oral liquid of three embodiments of the invention can improve the spleen index of mouse and thymus gland refers to There are pole significant difference in number, treatment group three compared with the control group;One treatment group two for the treatment of group significant difference compared with the control group It is different.
Test example 2, ConA inducing mouse Splenic vein hemodynamics experiment (mtt assay)
Gavage and grouping are sterile to each group mouse that spleen, splenocyte suspension processed is taken to be trained completely with RPMI1640 with test example 1 Nutrient solution adjusts a concentration of 3*10 of splenocyte9A/L carries out lymphproliferation response according to mtt assay in program, finally in 752 purples It is outer see at spectrophotometer 570nm wavelength survey its absorbance value (A), calculate ConA+ and each holes ConA- absorbance.Each dosage Group result carry out variance analysis compared with blank control group.As a result it see the table below:
Note:Compared with the control group, * P < 0.05, * * P < 0.01
As seen from the above table, the ginseng Ling oral liquid prepared by embodiment 1-3 has significant difference (P compared with the control group< 0.05), illustrate that present invention ginseng Ling oral liquid can promote ConA inducing mouse Splenic vein hemodynamics.
The present invention can be summarized with others without prejudice to the concrete form of the spirit or essential characteristics of the present invention.Therefore, nothing By from the point of view of which point, the embodiment above of the invention can only all be considered the description of the invention and cannot limit invention, Claims indicate the scope of the present invention, and above-mentioned explanation does not point out the scope of the present invention, therefore, with the present invention The comparable meaning and scope of claims in any variation, be all considered as being included within the scope of the claims.

Claims (4)

1. a seed ginseng Ling oral liquid, which is characterized in that be prepared by the raw material of following weight:22-27 parts of Radix Notoginseng, west 18-23 parts of American ginseng, 26-32 parts of ganoderma lucidum, 35-45 parts of matrimony vine, 2-4 parts of sika deer velvet antler, 7-12 parts of Radix Astragali, 7-12 parts of Radix Glycyrrhizae.
2. ginseng Ling oral liquid according to claim 1, which is characterized in that by the raw material preparation of following weight At:25 parts of Radix Notoginseng, 20 parts of American Ginseng, 30 parts of ganoderma lucidum, 40 parts of matrimony vine, 3 parts of sika deer velvet antler, 10 parts of Radix Astragali, 10 parts of Radix Glycyrrhizae.
3. a kind of method preparing ginseng Ling oral liquid as described in claim 1, which is characterized in that include the following steps:
(1) ultrasonic lixiviating effective components-total saposins after taking the Radix Notoginseng of weight, American Ginseng to crush;It first will be after crushing The weight ratio of Radix Notoginseng, American Ginseng petroleum ether and extracting n-butyl alcohol, liquid material used is 33:1, petroleum ether and n-butanol used it is dense Degree is 49.5%, and the volume ratio of petroleum ether and n-butanol used is 1:1;Then it is soaked again with a concentration of 70% EtOH Sonicate It carries, ultrasonic time is 28min/ times, and ultrasonic extraction 2 times, ultrasonic temperature is 50 DEG C, obtains saponin(e dry cream;
(2) ganoderma lucidum of weight, sika deer velvet antler, matrimony vine, Radix Astragali, licorice medicinal materials, through crushing using a concentration of 99.5% are taken Petroleum ether, the weight ratio of liquid material used is 25:1, it impregnates grease removal for 24 hours, is then extracted to remove deproteinized, most with sevage reagents A concentration of 75% ethyl alcohol is added afterwards, the weight ratio of alcohol precipitation ultrasound lixiviating effective components-total starches, liquid material used is 25:1, institute It is 1 with the volume ratio of ethyl alcohol and sevage reagents:1, ultrasonic temperature is 75 DEG C, and ultrasonic time is 30min/ times, ultrasonic extraction 2 It is secondary, obtain polysaccharide extraction liquid;
(3) the saponin(e dry cream obtained by step (1) is mixed with the polysaccharide extraction liquid obtained by step (2), being concentrated into liquid-solid ratio is 1.2:When 1, clarified solution is obtained with sedimentation separation method;
(4) into clarified solution obtained by step (3), addition flavouring agent joins Ling oral liquid to obtain the final product;The flavouring agent is matched by following parts by weight The raw material of ratio forms:1 part of citric acid, 25 parts of honey, 35 parts of xylitol;
The prepared Ling oral liquid relative density of joining of step (4) is 1.17, PH 4.5, general flavone 1.13%, and total reducing sugar is 14.23%, the clarification of product sepia, uniform color is consistent, palatable free from extraneous odour.
4. a kind of method preparing ginseng Ling oral liquid according to claim 3, which is characterized in that described in step (2) Sevage reagents are chloroform and a concentration of 99% n-butanol is 5 by volume:1 mixing gained.
CN201710941478.8A 2017-10-11 2017-10-11 Join Ling oral liquid and preparation method thereof Pending CN108567854A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710941478.8A CN108567854A (en) 2017-10-11 2017-10-11 Join Ling oral liquid and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710941478.8A CN108567854A (en) 2017-10-11 2017-10-11 Join Ling oral liquid and preparation method thereof

Publications (1)

Publication Number Publication Date
CN108567854A true CN108567854A (en) 2018-09-25

Family

ID=63576324

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710941478.8A Pending CN108567854A (en) 2017-10-11 2017-10-11 Join Ling oral liquid and preparation method thereof

Country Status (1)

Country Link
CN (1) CN108567854A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111991474A (en) * 2020-09-07 2020-11-27 深圳市桦健量子生物科技有限公司 Lucid ganoderma oral liquid and preparation method thereof
CN113186065A (en) * 2021-04-26 2021-07-30 吉林大清鹿苑保健科技有限公司 Health wine for enhancing immunity and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101385772A (en) * 2008-01-09 2009-03-18 姜宝库 Effervescence tablets for increasing natural immunity
CN101664185A (en) * 2009-09-07 2010-03-10 北京同仁堂健康药业股份有限公司 Food and medicament for enhancing immunity and relieving physical fatigue and preparation method
CN101816355A (en) * 2010-02-22 2010-09-01 李宏良 Anti-fatigue alternative tea and preparation method thereof
CN104055935A (en) * 2014-07-08 2014-09-24 朱正来 Traditional Chinese medicine composition for improving immunity in synergetic mode

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101385772A (en) * 2008-01-09 2009-03-18 姜宝库 Effervescence tablets for increasing natural immunity
CN101664185A (en) * 2009-09-07 2010-03-10 北京同仁堂健康药业股份有限公司 Food and medicament for enhancing immunity and relieving physical fatigue and preparation method
CN101816355A (en) * 2010-02-22 2010-09-01 李宏良 Anti-fatigue alternative tea and preparation method thereof
CN104055935A (en) * 2014-07-08 2014-09-24 朱正来 Traditional Chinese medicine composition for improving immunity in synergetic mode

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111991474A (en) * 2020-09-07 2020-11-27 深圳市桦健量子生物科技有限公司 Lucid ganoderma oral liquid and preparation method thereof
CN113186065A (en) * 2021-04-26 2021-07-30 吉林大清鹿苑保健科技有限公司 Health wine for enhancing immunity and preparation method thereof

Similar Documents

Publication Publication Date Title
CN103285231B (en) Medicine composition for diabetes adjunctive therapy and preparation method thereof
CN102308988B (en) Dendrobium health product having function of human body immunization enhancement
CN103992924B (en) The health drink of enhancing body immunizing power and making method thereof
CN102827750A (en) Maca health care liquor for improving organism immunity and sexuality
CN103463307B (en) Composite chewable tablet of Ganoderma Corydalis thalictrifolia Franch. (Radix Corydalis Thalictrifoliae) and preparation method thereof
CN111956753B (en) Medicinal and edible traditional Chinese medicine composition as well as preparation method and application thereof
CN112121144A (en) Roxburgh rose composition and preparation method and application thereof
CN102114102B (en) Traditional Chinese medicine extract mixed preparation and application thereof
CN102293927B (en) Compound Chinese medicinal preparation with antifatigue and antioxidation effects, and preparation method thereof
CN101732395B (en) Medicine or health food composition with immunoregulation effect and preparation method and application thereof
CN108567854A (en) Join Ling oral liquid and preparation method thereof
CN107432911B (en) Ginseng buccal tablet for preserving health and tonifying kidney and preparation method thereof
CN107836619A (en) A kind of beautiful millettia root solid beverage with strengthen immunity and antifatigue effect and preparation method thereof
CN103960663A (en) Health care food for enhancing immunologic function and preparation method of food
CN106581166A (en) Anti-fatigue food, health product or pharmaceutical composition
CN108522764B (en) Health-care herbal tea and preparation method thereof
CN106109521A (en) A kind of Radix Notoginseng oral liquid
CN105861238A (en) Compound fermented plateau pome health wine and production process thereof
CN110694008A (en) Dongshan longevity-prolonging and senescence-delaying composition and preparation method thereof
CN114365844B (en) Bamboo fungus compound health food for regulating intestinal flora and improving intestinal immunity and preparation method thereof
CN108782905A (en) Inonotus obliquus health protection tea and preparation method thereof and application
CN103211224A (en) Preparation process of compound health care food capable of rapidly recovering physical strength of man
CN104383232B (en) Clearing heat and detoxicating buccal lozenge of lectuce tea and its production method
CN113826882A (en) Dietary nutrition supplement for preventing and treating diabetes and preparation process thereof
CN104206939A (en) Kidney-tonifying tortoise herb jelly

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20180925

RJ01 Rejection of invention patent application after publication